CONMED Orthopedic Sales Surge on Healthy End Markets

CONMED reported 2Q23 orthopedic sales of $140.8 million, +17.2% compared to 2Q22. For the first half of 2023, the company generated $272 million in orthopedic sales, +19.5% compared to the prior year.

Improved commercial execution, a porfolio more focused on high-growth products and healthy end markets drove CONMED's terrific start to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us